A client who has an adenocarcinoma of the descending colon with a partial obstruction is receiving doxorubicin (adriamycin) intravenously (iv) to reduce the tumor mass. the nurse monitors the client for signs and symptoms of doxorubicin toxicity. what clinical finding indicates that toxicity has occurred

Question

Selena Mccormick

Biology

15 September, 00:51

A client who has an adenocarcinoma of the descending colon with a partial obstruction is receiving doxorubicin (adriamycin) intravenously (iv) to reduce the tumor mass. the nurse monitors the client for signs and symptoms of doxorubicin toxicity. what clinical finding indicates that toxicity has occurred

+2

Answers (2)

Know the Answer?

Simone Wu · Answer 1

Toxicity of doxorubicin can be identified by abnomalitied incardiac rhythm. Doxorubicin is known to be cardiotoxic. This is seen in the inconsistent electrocardiography (ECG) abnomalities. Alopecia can at times be confused with being a toxic effect of doxorubicin but it is a side effect.

Conner Hanson · Answer 2

Abnormalities in cardiac rhythm

Doxorubicin is cardiotoxic, which is manifested by transient ECG abnormalities. Alopecia is an expected side effect of doxorubicin, not a toxic effect.